Fall 2023 Vol. 13 Issue 03
From the Editor-in-Chief
Immunotherapy Gets Personal
Therapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
Your Cancer Guide
The Art of Deflection
Casual conversations can take unwelcome turns after you’ve been diagnosed with cancer. Here’s how to respond when people say the wrong things.
by Hester Hill Schnipper
Caregiving With Confidence
Caregivers can take steps to encourage patients to have more healthy dialogue about strong emotions.
by K.J. Bannan
Clinical Trials That Reflect Real-world Patients
A recent article discusses challenges and practical solutions for working toward more diverse and equitable oncology clinical trials.
by Nicholas Warren, PhD
Immunotherapy: When Is Sooner Better Than Later?
Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
Making Clinical Trials Easier
Clinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.
by Cameron Walker
Initially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
Pulling Back the Research Curtain
Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
A Bountiful Harvest
Food for the Cure provides fresh produce to people with cancer.
by Thomas Celona
Facts and Stats
Will We Make the Moonshot?
As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles StarrGermline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon KelveyProgress in Lung Cancer
November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.Against All Odds
At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren